We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
-6.21%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$148M
AUM Growth
-$12.3M
Cap. Flow
+$11.9M
Cap. Flow %
8.04%
Top 10 Hldgs %
74.02%
Holding
35
New
1
Increased
2
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$7.64M
2
ALT icon
Altimmune
ALT
+$4.09M
3
CRDL
Cardiol Therapeutics
CRDL
+$212K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 68.41%
2 Materials 20.1%
3 Industrials 1.98%
4 Consumer Staples 1.26%
5 Financials 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGLD icon
26
Royal Gold
RGLD
$19.5B
$945K 0.64%
7,550
– –
NOC icon
27
Northrop Grumman
NOC
$81.2B
$944K 0.64%
2,165
– –
MREO
28
Mereo BioPharma
MREO
$47.3M
$938K 0.63%
260,470
– –
CVS icon
29
CVS Health
CVS
$122B
$857K 0.58%
14,500
– –
DEO icon
30
Diageo
DEO
$53.6B
$851K 0.57%
6,750
– –
NEWP
31
New Pacific Metals
NEWP
$1.17B
$728K 0.49%
485,000
– –
SKE
32
Skeena Resources
SKE
$4.04B
$208K 0.14%
38,786
– –
CRDL
33
Cardiol Therapeutics
CRDL
$164M
$202K 0.14%
+100,000
New +$212K
IRD
34
Opus Genetics
IRD
$302M
$153K 0.1%
100,000
– –
1
2

Similar funds

FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return
V
ViaWealth Leawood, Kansas $180M AUM 20.16% 1-Year Est. Return
RVM
Robinson Value Management San Antonio, Texas $180M AUM 24.17% 1-Year Est. Return

Knoll Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Knoll Capital Management held 35 positions worth $148M, down 7.7% from $161M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Knoll Capital Management deployed $11.9M of net new capital in Q2 2024, opening 1 new position and adding to 2 existing holdings. Its largest new stake was Cardiol Therapeutics: 100,000 shares worth $202K.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, down from 72% a quarter earlier, followed by Materials and Industrials.

  • Knoll Capital Management's largest Q2 2024 buy was Cardiol Therapeutics: 100,000 shares worth $202K.
  • Knoll Capital Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2024, an estimated $7.64M increase.
  • Knoll Capital Management's ten largest holdings make up 74% of its $148M portfolio in Q2 2024.
  • Knoll Capital Management opened 1 new position and closed 0 in Q2 2024.
  • Knoll Capital Management's portfolio value fell 7.7% quarter-over-quarter to $148M.

Based on Knoll Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.